Limula
La Tour-de-peilz · Founded 2020
About Limula
Limula provides a unique platform technology enabling scale out of cell therapy production. Our patent-granted solution is combining a bioreactor and a centrifuge into one device, for the first time. Our product is composed of hardware, software and consumables, allowing healthcare providers to safely manufacture CGT in a decentralised manner. By bringing manufacturing closer to the patients, our solution will broaden access to these highly personalised treatments.
Company Facts
- Founded: 2020
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $15.7M
- Funding stage: Seed
- Last round: Debt Financing (Dec 2024)
- Website: https://www.limula.ch
- Phone: +41 44 585 31 18
Industries & Categories
Biotechnology, Genetics, Manufacturing, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/limula-56684 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.